HealthLynked (HealthLynked) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is HealthLynked Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of HealthLynked is: No Data: Cannot be evaluated.

Competitive Comparison of HealthLynked's Risk Assessment

For the Medical Care Facilities subindustry, HealthLynked's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HealthLynked's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthLynked's Risk Assessment distribution charts can be found below:

* The bar in red indicates where HealthLynked's Risk Assessment falls into.

HealthLynked (OTCPK:HLYK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

HealthLynked Risk Assessment Related Terms

Thank you for viewing the detailed overview of HealthLynked's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthLynked (HealthLynked) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthLynked Corp (OTCPK:HLYK) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1265 Creekside Parkway, Suite 302, Naples, FL, USA, 34108

Website

https://www.healthlynked.com

HealthLynked Corp operates a cloud-based online personal medical information and records archiving system for patients and doctors to keep track of medical information via the Internet in a cloud-based system. It operates in four segments: Health Services, Digital Healthcare, ACO/MCO, and Medical Distribution. The majority of its revenue is generated from the Health Services segment, which is into operations of Naples Women's Center, Naples Center for Functional Medicine, and Bridging the Gap Physical Therapy.

Executives

Robert P Gasparini	director	12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Daniel L. Hall	director	C/O HEALTHLYNKED CORP., 1035 COLLIER CENTER WAY SUITE 3, NAPLES FL 34110
Heather Monahan	director	520 WEST AVE., #1704, MIAMI BEACH FL 33139
Paul Hobaica	director	1265 CREEKSIDE PARKWAY, SUITE 302, NAPLES FL 34108
Robert P. Mino	director	1072 LAKESHORE DR., JUPITER FL 33458
George O'leary	director, officer: Chief Financial Officer	C/O ISONICS CORPORATION, 5906 MCINTYRE STREET, GOLDEN CO 80403
Michael T Dent	director, 10 percent owner, officer: Chief Executive Officer	12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913